TERN
Terns Pharmaceuticals, Inc. · Healthcare
CEO Amy L. Burroughs sold $2.7M of Terns Pharmaceuticals, Inc.
Sold$2,718,230
$38.10Price
71,339Shares
−33%Stake
What TERN did after the filing
- The stock from Wed, Jan 7 open, $37.89
- +3.5%
- S&P 500, same days
- −0.4%
Measured over 30 trading days, to the Feb 20 close.
Traded Mon, Jan 5. Filed Tue, Jan 6, 8:26 PM ET, after the close. Returns use the Jan 7 open and the Feb 20 close. Not investment advice.